3 hrs ago | Wall St. Cheat Sheet
Analysts Upgrade and Downgrade These Stocks Today
Wall St. Watchdog reveals information about companies for which stock analysts either upgraded or downgraded the shares on February 13th: UBS upgraded its rating on this company from Sell to Neutral and changed its price target from $49 to $72. BMO Capital Markets upgraded its rating on this company from Underperform to Market Perform and changed ... (more)
7 hrs ago | The Washington Post
AmerisourceBergen, Arch, Monster Worldwide: U.S. Equity Movers
Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 10:45 a.m. in New York.
7 hrs ago | AmericanBankingNews.com
AmerisourceBergen Corp. Shares Downgraded to "Neutral" by Robert W. Baird Analysts
AmerisourceBergen Corp. was downgraded by research analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating in a report issued on Monday.
10 hrs ago | Reuters
AmerisourceBergen CFO DiCandilo resigns
Guttman was previously vice president of finance of Syncor International, and held financial planning and financial services managerial positions at Disney Consumer Products, Pizza Hut Inc and PepsiCo Inc.
10 hrs ago | Drugs.com
AmerisourceBergen Announces Departure of Chief Financial Officer...
VALLEY FORGE, Pa.-- --Feb 13, 2012 - AmerisourceBergen Corporation today announced that Michael D. DiCandilo, the Company's Executive Vice President and Chief Financial Officer, has left the Company to pursue other interests, effective immediately.
11 hrs ago | Seeking Alpha
AmerisourceBergen (ABC) announces that CFO Michael DiCandilo has left ...
AmerisourceBergen announces that CFO Michael DiCandilo has left the company, effective immediately.
Build A Healthier Portfolio With These 5 Stocks
The healthcare industry has long been an option both for patients to get healthy and for investors to increase the worth of their portfolios.
More money for meetings (and drugs for free)a
It's big - the company's market-cap is over $10 billion, and its revenues in the fiscal year that ended September 30 were more than $80 billion.
Brecon Pharmaceuticals Expands Capacity With Significant Investment ...
Herefordshire, UK Commercial packaging and clinical trials services specialist Brecon Pharmaceuticals announces the expansion of its storage and distribution capacity, with investment in a state-of-the-art, purpose-built facility in South Wales, UK.
AmerisourceBergen Corporation Approves Quarterly Dividend
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia VALLEY FORGE, Pa.-- --The Board of Directors of AmerisourceBergen Corporation today declared a cash dividend of $0.13 per share on Common Stock, payable March 5, 2012, to ... (more)
AmerisourceBergen is one of the world's largest pharmaceutical services companies with operations primarily in the United States, Canada.
Earnings Watch: 2 Stocks Warm on Trading Screens Today
McKesson Corporation reported its results for the third quarter. Net income for McKesson Corporation rose to $300 million vs.
SADIF Analytics releases new summary due diligence reports for American stocks
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering the following companies: Report Summary for: AmerisourceBergen Corp.
Accountant I - Supplier Incentives
Thank you for your interest in the Accountant I - Supplier Incentives . To begin the application process, please enter your email address.
Zacks Investment Research Analysts Reaffirm a "Neutral" Rating on AmerisourceBergen
AmerisourceBergen 's stock had its "neutral" rating reiterated by Zacks Investment Research in a report issued on Friday.
Reimbursement Counselor/Benefit Verification Specialist
Thank you for your interest in the Reimbursement Counselor/Benefit Verification Specialist.
AmerisourceBergen Corporation Reports $0.62 in Diluted EPS, a 9%...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia AmerisourceBergen Corporation Reports $0.62 in Diluted EPS, a 9% Percent Increase, and Revenue of $20.4 Billion for the December Quarter VALLEY FORGE, Pa.-- --AmerisourceBergen ... (more)
AmerisourceBergen's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the AmerisourceBergen first quarter earnings.
AmerisourceBergen Posts EPS In Line - Analyst Blog
AmerisourceBergen Corporation posted first quarter fiscal 2012 adjusted earnings of 63 cents per share, in line with the Zacks Consensus Estimate.
AmerisourceBergen Corp Earnings: Profit Rises for Third Straight Quarter
S&P 500 component AmerisourceBergen Corporation reported its results for the first quarter.
Also on Topix